Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Severe or lethal toxicities upon capecitabine intake: is DPYD genetic polymorphism the ideal culprit?

× No keyword cloud information.

8 in total

1. Beating the odds: efficacy and toxicity of dihydropyrimidine dehydrogenase-driven adaptive dosing of 5-FU in patients with digestive cancer.

Authors: Manon Launay; Laetitia Dahan; Manon Duval; Anne Rodallec; Gérard Milano; Muriel Duluc; Bruno Lacarelle; Joseph Ciccolini; Jean-Francois Seitz
Journal: Br J Clin Pharmacol Date: 2015-11-28 Impact factor: 4.335

Review 2. Integrating pharmacogenetics into gemcitabine dosing--time for a change?

Authors: Joseph Ciccolini; Cédric Mercier; Laetitia Dahan; Nicolas André
Journal: Nat Rev Clin Oncol Date: 2011-02-08 Impact factor: 66.675

3. UPFRONT DPD DEFICIENCY DETECTION TO SECURE 5-FU ADMINISTRATION: PART 2- APPLICATION TO HEAD-AND-NECK CANCER PATIENTS.

Authors: Manon Launay; Joseph Ciccolini; Claire Fournel; Carmelo Blanquicett; Charlotte Dupuis; Nicolas Fakhry; Florence Duffaud; Sébastien Salas; Bruno Lacarelle
Journal: Clin Cancer Drugs Date: 2017

4. Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency.

Authors: Maurice C van Staveren; Barbara Theeuwes-Oonk; Henk Jan Guchelaar; André B P van Kuilenburg; Jan Gerard Maring
Journal: Cancer Chemother Pharmacol Date: 2011-05-18 Impact factor: 3.333

5. Heparin-induced thrombocytopenia in a patient with colon cancer.

Authors: Ajaz Nabi Koul; Ridwana Ahad
Journal: Indian J Med Paediatr Oncol Date: 2013-10

6. Dihydropyrimidine dehydrogenase polymorphisms and fluoropyrimidine toxicity: ready for routine clinical application within personalized medicine?

Authors: Marzia Del Re; Antonello Di Paolo; Ron H van Schaik; Guido Bocci; Paolo Simi; Alfredo Falcone; Romano Danesi
Journal: EPMA J Date: 2010-07-25 Impact factor: 6.543

7. Discovery of novel mutations in the dihydropyrimidine dehydrogenase gene associated with toxicity of fluoropyrimidines and viewpoint on preemptive pharmacogenetic screening in patients.

Authors: Marzia Del Re; Angela Michelucci; Angelo Di Leo; Maurizio Cantore; Roberto Bordonaro; Paolo Simi; Romano Danesi
Journal: EPMA J Date: 2015-09-02 Impact factor: 6.543

8. Emergency use of uridine triacetate for the prevention and treatment of life-threatening 5-fluorouracil and capecitabine toxicity.

Authors: Wen Wee Ma; Muhammad Wasif Saif; Bassel F El-Rayes; Marwan G Fakih; Thomas H Cartwright; James A Posey; Thomas R King; Reid W von Borstel; Michael K Bamat
Journal: Cancer Date: 2016-09-13 Impact factor: 6.860

8 in total